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Abstract
 
Signaling pathways involved in regulating T cell proliferation and survival are not well under-
stood. Here we have investigated a possible role of the nuclear factor (NF)-
 
 
 
B pathway in reg-
ulating mature T cell function by using CD4
 
  
 
T cells from p50
 
    
 
cRel
 
    
 
mice, which exhibit
virtually no inducible 
 
 
 
B site binding activity. Studies with these mice indicate an essential role
of T cell receptor (TCR)-induced NF-
 
 
 
B in regulating interleukin (IL)-2 expression, cell cy-
 
cle entry, and survival of T cells. Our results further indicate that NF-
 
 
 
B regulates TCR-
induced expression of antiapoptotic Bcl-2 family members. Strikingly, retroviral transduction
of CD4
 
  
 
T cells with the NF-
 
 
 
B–inducing I
 
 
 
B kinase 
 
  
 
showed that NF-
 
 
 
B activation is not
only necessary but also sufficient for T cell survival. In contrast, our results indicate a lack of in-
 
volvement of NF-
 
 
 
B in both IL-2 and Akt-induced survival pathways. In vivo, p50
 
    
 
cRel
 
   
 
mice showed impaired superantigen-induced T cell responses as well as decreased numbers of
effector/memory and regulatory CD4
 
  
 
T cells. These findings provide the first demonstration
of a role for NF-
 
 
 
B proteins in regulating T cell function in vivo and establish a critically im-
portant function of NF-
 
 
 
B in TCR-induced regulation of survival.
Key words: T lymphocytes • T cell receptor • cell death • NF-
 
 
 
B • transcription factor
 
Introduction
 
Activation of CD4
 
  
 
Th cells is a critical step in initiating an
adaptive immune response. Two signals, both of which are
delivered by APCs, are required for activation-induced
proliferation of Th cells: (a) engagement of the TCR by an
antigen–MHC complex on APCs, and (b) engagement of
costimulatory molecules, the best characterized of which is
CD28, with the B7 family of proteins expressed by APCs.
TCR and CD28-induced pathways synergize in stimulat-
ing T cell proliferation and in regulating expression of
growth promoting cytokines, such as IL-2 (1–3). Signifi-
cantly, T cell responses are also intimately dependent upon
survival-promoting signals induced by TCR, CD28, and
cytokine receptors.
Antigen encounter by T cells induces both proliferative
and survival pathways, which drive T cell expansion and
lead to the development of immunity. Conversely, after
antigen is cleared, cessation of T cell–APC engagement can
result in rapid induction of cell death (4, 5). This mode of
T cell death, referred to as “passive” cell death, is thought
to be crucial for terminating an immune response and
maintaining T cell homeostasis (5). The best-defined sur-
vival pathways in T cells involve growth-promoting cyto-
kines, such as IL-2, or costimulatory molecules, such as
CD28, that appear to function by activating the antiapop-
totic kinase, Akt (see below). TCR engagement itself also
provides protection through a signaling pathway that has
not yet been defined. In contrast, when T cells encounter
high concentrations of antigens (e.g., autoantigens), TCR
signals promote apoptosis either by triggering death recep-
tors such as Fas or TNFR1 (4–6), or by activating the
proapoptotic molecule Bim (7). This form of T cell death is
referred to as “activation-induced” cell death and helps
prevent autoimmunity. Thus, regulation of T cell responses
is dependent upon both antiapoptotic and proapoptotic sig-
naling pathways.
T cell activation is initiated by protein tyrosine kinases,
which induce the activation of multiple signaling pathways
(8). Several transcription factors have been shown to be ac-
tivated by TCR, CD28, and cytokine receptor engage-
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ment, including those belonging to the Ets, NFAT, AP-1,
nuclear factor (NF)
 
*
 
-
 
 
 
B, and signal transducer and activa-
tor of transcription families (9). However, the specific roles
played by these factors in regulating T cell activation and
survival is only beginning to be understood. Gene targeting
studies have recently shed some light on the function of
these transcription factors in T cells. Studies of mature T
cells singly or doubly deficient in NFAT proteins (10) have
primarily revealed defects in T cell differentiation rather
than activation or survival (11–13). c-Jun
 
    
 
T cells also
show no proliferative defects (14) whereas the role of other
AP-1 family proteins in T cells is still unclear. Recent stud-
ies have indicated that the PI3K/Akt pathway is a key sur-
vival mediator of both CD28 and IL-2R (15–18). How-
ever, it is not known how the Akt protein kinase blocks
apoptosis in T cells, although NF-
 
 
 
B is thought to be one
of the targets of Akt (18–21).
The NF-
 
 
 
B transcription factors are key regulators of in-
flammatory and immune response genes (22). NF-
 
 
 
B activa-
tion is controlled by signal-dependent phosphorylation of
NF-
 
 
 
B–associating I
 
 
 
B inhibitory proteins by I
 
 
 
B kinases
(IKK
 
  
 
and IKK
 
 
 
; reference 23). Phosphorylated I
 
 
 
B pro-
teins are rapidly degraded, allowing translocation of NF-
 
 
 
B
to the nucleus. Recent studies have shown an important role
for NF-
 
 
 
B proteins in regulating cell death in many different
cell types (22), including B cells (24–26) and dendritic cells
(DCs; reference 27). In T cells, NF-
 
 
 
B is activated by both
TCR and CD28 engagement and comprises of p50
 
 
 
RelA
and p50
 
 
 
cRel heterodimers and p50 homodimers (28).
However, in vitro proliferative responses in p50
 
   
 
, RelA
 
   
 
,
and cRel
 
    
 
CD4
 
  
 
T cells are only moderately reduced
compared with WT T cells (28). In contrast, proliferation of
p50
 
    
 
cRel
 
    
 
doubly deficient T cells is drastically re-
duced, indicating important but redundant functions for p50
and cRel in T cells (28). NF-
 
 
 
B function in T cells has also
been studied in transgenic (Tg) mice expressing a degrada-
tion-resistant form of the I
 
 
 
B
 
  
 
inhibitor in T cells (29–31).
Studies of I
 
 
 
B-Tg T cells also showed impaired in vitro pro-
liferative responses (29). Gene targeting studies of PKC
 
  
 
and
Bcl-10 have revealed both impaired NF-
 
 
 
B activation and T
cell proliferative responses in vitro (32, 33). However, im-
paired proliferation may result from defects in cell cycle reg-
ulation and/or decreased survival of activated T cells. Studies
to date have not discriminated between these different possi-
ble functions for NF-
 
 
 
B in T cells. Significantly, the possible
function of NF-
 
 
 
B in regulating TCR, CD28, and cytokine
receptor–induced pathways has not been determined. Fi-
nally, in vitro studies of T cell function may not accurately
reflect in vivo events. At present, the in vivo function of
NF-
 
 
 
B in T cells remains to be addressed.
Here we have examined the function of NF-
 
 
 
B in regu-
lating mature T cell signaling pathways by using p50
 
   
 
cRel
 
    
 
CD4
 
  
 
T cells, which have virtually no inducible
NF-
 
 
 
B activity. We show that NF-
 
 
 
B plays essential roles
in regulating TCR-induced cell cycle entry and survival
both in vitro and in vivo. In contrast, NF-
 
 
 
B is not neces-
sary for survival pathways induced by Akt or IL-2. Our
findings define NF-
 
 
 
B as a key participant in the TCR-
induced survival pathway that is not only essential but also
sufficient for maintaining T cell survival.
 
Materials and Methods
 
Isolation, Activation, and Cell Division Analysis of CD4
 
 
 
T Cells
 
p50
 
    
 
cRel
 
    
 
mice were generated by crossing p50
 
    
 
mice
(34) with cRel
 
    
 
mice (provided by S. Gerondakis, The Walter
and Eliza Hall Institute of Medical Research, The Royal Mel-
bourne Hospital, Victoria, Australia; reference 35). OTII
 
 
 
IL-2
 
   
 
mice were generated by crossing OT-II mice (36) with IL-2
 
   
 
mice (37). All mice were used between 2 to 4 mo after birth.
CD4
 
  
 
T cells were isolated from mouse spleens using CD4
 
 
 
Dynabeads (Dynal) according to the manufacturer’s instructions.
Isolated T cells were cultured in T cell medium (RPMI contain-
ing 10% FBS, 2 mM 
 
l
 
-glutamine, 100 U/ml penicillin, 100 U/ml
streptomycin, 0.1 mM nonessential amino acids, 1 mM sodium
pyruvate, 10 mM Hepes, and 0.1 mM 2-mercaptoethanol;
GIBCO BRL). T cells were activated by culture in the presence
of 1 
 
 
 
g/ml plate-bound 
 
 
 
CD3 and 1 
 
 
 
g/ml 
 
 
 
CD28 (BD Bio-
sciences) monoclonal antibodies. In some experiments, 20 ng/ml
murine IL-2 (R&D Systems) was also added to T cell culture me-
dia. For proliferation analysis, naive CD4
 
  
 
T cells were incubated
in T cell media containing 1 
 
 
 
M 5-chloromethylfluorescein di-
acetate (Molecular Probes) at 37
 
 
 
C for 30 min, washed twice,
and cultured under different activation conditions for 1–3 d be-
fore FACS
 
® 
 
analysis. 5-chloromethylfluorescein diacetate breaks
into carboxyfluorescein diacetate succinimidyl ester (CFSE) in
cells and then the latter covalently associates with cellular pro-
teins. When a cell divides, CFSE gets evenly distributed in two
cells. Each cell division causes a “left shift” in the FACS
 
® 
 
histo-
graph of 
 
 
 
0.3 log scale units. CFSE analysis was performed on
living cells after gating on them based on their forward and side
scatter characteristics.
 
FACS
 
®
 
, Electrophoretic Mobility Shift Assay (EMSA),
RT-PCR, and Northern Analysis
 
PE-
 
 
 
CD4, PerCP-
 
 
 
CD4, FITC-
 
 
 
CD8, PE-
 
 
 
B220, FITC-
 
 
 
CD3, FITC-
 
 
 
CD25, PE-
 
 
 
CD25, FITC-
 
 
 
TCRV
 
 
 
6, FITC-
 
 
 
TCRV
 
 
 
8, FITC-
 
 
 
CD44, and PE-
 
 
 
CD62L antibodies were
purchased from BD Biosciences. FACS
 
® 
 
analysis was performed
on a FACSCalibur
 
® 
 
cytometer (Becton Dickinson). EMSAs were
performed as previously described (28). The hairpin oligo-
nucleotide probes used were GAGAGGGGATTCCCCGAT-
TACCTTTCGGGGAATCCCCTCT (H2 site) and GAGA-
GGGGAATCTCCCATTAGCTTTGGGAGATTCCCCTCT
(IL-2R
 
  
 
site). Total RNA of T cells stimulated under different
conditions were extracted using TRI reagent (Molecular Re-
search Center) as recommended by the manufacturer. RT was
performed using PRO-Star RT-PCR First Strand Kit from Strat-
agene according to the manufacturer’s instructions. The primers
used in the experiments were: IL-2: 5
 
  
 
primer AACAGCGCA-
CCCACTTCAA, 3
 
  
 
primer TTGAGATGATGCTTTGACA;
c-Myc: 5
 
  
 
primer CGACGATGCCCCTCAACGTG, 3
 
  
 
primer
 
*Abbreviations used in this paper: CFSE, carboxyfluorescein diacetate suc-
cinimidyl ester; DC, dendritic cell; EMSA, electrophoretic mobility shift
assay; GFP, green fluorescent protein; NF, nuclear factor; PI, propidium
iodide; SEB, staphylococcal enterotoxin B; Tg, transgenic.T
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CGAGTTAGGTCAGTTTATGC; Bcl2: 5   primer GCTTC-
TTTTCGGGGAAGGAT, 3  primer AAGCCCAGACTCAT-
TCAACC; Bcl-XL: 5   primer AAG CAA GCG CTG AGA
GAG GCA, 3  primer ACA GTC ATG CCC GTC AGG AAC;
and   actin: 5  primer ATGGATGACGATATCGCT, 3  primer
ATGAGGTAGTCTGTCAGGT. Northern blotting was per-
formed as previously described (38), using specific radiolabeled
cDNA probes for Bcl2, Bcl-XL, and   actin genes.
Staphylococcal Enterotoxin B (SEB) Challenge Experiments
WT and p50    cRel    mice were injected intravenously
with 50  g SEB (Toxin Technology). Mice were killed before
injection (day 0) and 3 and 6 d after injection. Splenocytes were
double stained with CD4 and TCR-V 8 or TCR-V 6 antibod-
ies to determine the percentage of V 8  or V 6  T cells in total
CD4  T cell population.
Retroviral Infection of CD4  T Cells and Infected Cell
Survival Assays
The constitutively active IKK  mutant, IKK (EM), which
contains both EE and M10 mutations, was provided by M. Del-
hase and M. Karin (University of California San Diego, San Di-
ego, CA; reference 39). It was subcloned into murine stem cell
virus internal ribosome entry site green fluorescent protein
(GFP; MIG) retroviral expression vector (16). MIG-Bcl2 and
MIG-MyrAKT constructs have been described (15, 16). Retro-
viruses were produced by transfecting BOSC 293T cells (40)
with retroviral plasmid DNA and the pCL-Eco packaging
plasmid.
During infection, WT and p50    cRel    T cells were acti-
vated with 1  g/ml  CD3 and 1  g/ml  CD28 in the presence
of 20 ng/ml IL-2. OTII T cells were activated with 1  g/ml
OVA peptide in the presence of 10 ng/ml IL-2. CD4  T cells
were spin infected at 2,500 rpm for 1 h at 30 C on days 1 and 2
of T cell activation. Viable cells were harvested on day 4 by Ficoll
(Amersham Biosciences) gradient centrifugation. Because all ret-
roviral constructs based on MIG vector contain an internal ribo-
some entry site GFP cassette, infected cells were distinguished
from uninfected cells by GFP expression using FACS®. T cell
survival assays were performed as follows: after infection, viable T
cells were obtained by Ficoll spin. Then, the percentage of GFP 
cells was determined by FACS®. This was the starting time point
T0 (day 0). These T cells were plated in T cell medium without
 CD3 antibody. At different time points Tn (days 1, 2, and 3),
cells were stained with 2.5  g/ml propidium iodide (PI) for 10
min before FACS® analysis. Viable infected T cells were repre-
sented by the GFP  PI  population. The survival rate of the in-
fected T cells was calculated according to this formula: (the per-
centage of GFP  PI  cells at Tn)/(the percentage of GFP  PI 
cells at T0)   100.
Cell Death Assays
DNA Content Staining.  DNA content staining was per-
formed as previously described (28). In brief, T cells were fixed at
4 C in 70% ethanol for 24 h and stained with a PI staining solution
(PBS containing 50  g/ml PI, 100 U/ml RNase A, and 1 mg/ml
glucose) for 2 h at room temperature before FACS® analysis. Apop-
tosis was determined by quantification of the sub-G0 population.
Passive Cell Death Determination. After 3 d of activation,
CD4  T cells were harvested by Ficoll (Amersham Biosciences)
density gradient centrifugation. Typically, T cells obtained by
this method contained  5% dead cells. These T cells were
plated in T cell medium, with or without 20 ng/ml IL-2 for 1 or
2 d before being assayed for apoptosis by DNA content staining
and quantification of the sub-G0 population. In certain experi-
ments, SYTOX was used to stain the apoptotic cell population.
SYTOX (Molecular Probes) is a fluorescent dye that emits a
strong green fluorescence after binding to DNA. Cells were
double stained with PE- CD25 and SYTOX (2 nM in PBS) be-
fore FACS® analysis. Apoptosis rate was calculated using this for-
mula: (percentage of CD25  SYTOX  cells)/(percentage of total
CD25  cells)   100.
Cell Death of Retrovirus-infected T Cells. This is described
above in the section on retrovirus infection.
Results
Normal T Cell Development in the Absence of p50 and
cRel. Amongst known NF- B subunits, p50, cRel, and
RelA comprise a large proportion of NF- B activity in
mature T lymphocytes (28). Although T cell development
is normal in p50   , cRel   , or RelA    mice, doubly de-
ficient p50    RelA    and IKK     mice lack lympho-
cytes, probably because of impaired survival of com-
mon  lymphocyte precursors (34, 35, 41–44). Because
p50 RelA and p50 cRel heterodimers comprise two
major NF- B complexes in many cell types, including T
cells, we determined the consequence of the absence of
p50 and cRel on lymphocyte development. p50    and
cRel    mice (34, 35) were interbred to obtain p50   
cRel    mice, which were fertile and apparently healthy.
As shown in Fig. 1 A, no differences in the numbers of
double-positive and CD4 and CD8 single-positive thy-
mocytes were noticed between WT and p50    cRel   
mice. Mature T and B cells were also present in normal
numbers in the spleens of p50    cRel    mice, as were
CD4  and CD8  T cells (Fig. 1 B). We have also found
that DC development proceeds normally in these mice
(27). Expression of the CD3 component of the TCR was
indistinguishable between WT and p50    cRel    CD4 
T cells (Fig. 1 C).
To determine the specific consequence of engagement
of TCR and CD28 on NF- B activation in WT and
p50    cRel    CD4  T cells, we used plate-bound anti-
CD3 ( CD3) and anti-CD28 ( CD28) monoclonal anti-
bodies. EMSA analysis showed that in WT T cells, nuclear
NF- B activity binding with the high affinity H-2 or IL-
2R  (CD25)  B sites was significantly enhanced after a 6-h
stimulation with  CD3 or  CD3  CD28 (Fig. 1 D). The
two indicated complexes have previously been character-
ized as heterodimers of p50 with RelA and cRel (complex
1) or homodimers of p50 (complex 2; reference 28). As
expected from previous studies,  CD3-induced NF- B
activity could be enhanced in the presence of  CD28 (Fig.
1 D, bottom). Strikingly, both constitutive and  CD3-
inducible  B site binding activities were virtually abol-
ished in p50    cRel    T cells (Fig. 1 D). Furthermore,
CD3 CD28 engagement did not enhance  B site bind-
ing activity in p50    cRel    T cells. Similar results
were also obtained when T cells were used after 3 d of ac-
tivation (unpublished data). These results demonstrate thatT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
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p50 cRel comprise a major proportion of NF- B activity
in mature CD4  T cells, as they do in mature B cells and
DCs (27, 35, 45).
We then tested for the presence of RelA and p52, two
NF- B subunits that may substitute for p50 and cRel in
p50    cRel    T cells. As previously shown (28) and in
Fig. 1 E, the  B site binding activity in  CD3  CD28–
stimulated WT T cells is reduced by a RelA Ab (complex
1) and a p100/p52 Ab (complex 2). In contrast, the RelA
Ab did not affect p50    cRel    T cell DNA binding ac-
tivity although reactivity was evident with the p100/p52
Ab (complex 3). Importantly, RelA protein levels were no
different between WT and p50    cRel    T cells (unpub-
lished data). Thus, lack of RelA DNA binding in p50   
cRel    T cells is not due to absence of RelA protein. Al-
though it is unclear why RelA DNA binding is not de-
tected in p50    cRel    T cells, a likely explanation might
be that in the absence of p50 and cRel, RelA remains mo-
nomeric and/or forms homodimers. Although monomeric
RelA cannot bind DNA, previous studies have shown that
RelA homodimers poorly bind DNA compared with het-
erodimers with p50 (46), which may also explain why
RelA is typically present in heterodimeric complexes with
these proteins. Thus, the absence of p50 and cRel also di-
minishes the formation of RelA DNA binding complexes,
resulting in further reduction in  B site binding activity.
Overall, these results indicate that the normal development
and greatly reduced  B site binding activity in p50   
cRel    CD4  T cells make them an excellent tool for
studying NF- B function in mature T cells.
Impaired Cell Cycle Entry after TCR Stimulation of p50   
cRel    T Cells In Vitro. Using p50    cRel    cells, we
first determined the role of NF- B in cell cycle regulation
of CD4  T cells. To this end, WT and p50    cRel    cells
were stimulated with  CD3 for 2 d, after which DNA
content per cell was quantified to simultaneously determine
potential defects in regulation of cell cycle and cell survival.
 CD3 treatment of WT T cells induced significant cell cy-
cle entry, evidenced by S and G2/M phase cells (Fig. 2 A).
In contrast, very few S and G2/M phase cells were de-
Figure 1. Combined absence of
p50 and cRel NF- B subunits does
not affect T cell development. (A)
FACS® analysis of CD4 and CD8 ex-
pression in WT and p50    cRel   
thymocytes. (B) FACS®  analysis of
B220, CD3, CD4, and CD8 expres-
sion in WT and p50    cRel    sple-
nocytes. (C) CD3 expression level in
WT and p50     cRel     CD4   T
cells. FACS® was performed by gat-
ing on CD4  cells. (D) EMSAs were
performed with nuclear extracts from
naive CD4  T cells either untreated
or activated with 1  g/ml plate-
bound   CD3 or 1  g/ml plate-
bound  CD3 plus 1  g/ml  CD28
for 6 h. NF- B binding sites used
were from H-2Kb  and IL-R 
(CD25). Complexes 1 and 2 are de-
scribed in the text. (E) EMSAs were
performed with nuclear extracts from
naive CD4  T cells activated with 1
 g/ml plate-bound  CD3 plus 1
 g/ml  CD28 for 6 h. NF- B bind-
ing site was from H-2Kb. The addi-
tion of antibodies to RelA and p100/
p52 is indicated.T
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865 Zheng et al.
tected after  CD3 treatment of p50    cRel    T cells.
Significantly, a large proportion of p50    cRel    cells un-
derwent apoptosis as evidenced by the sub-G0 population
(Fig. 2 A). However, costimulation of p50    cRel    cells
with  CD28 significantly enhanced cell cycle entry and re-
duced the number of apoptotic cells (Fig. 2 A), suggesting a
potentially NF- B–independent role for CD28 in regulat-
ing these processes. In contrast, the addition of exogenous
IL-2 did not significantly affect T cell survival or cell cycle
entry (Fig. 2 A). Next, we determined whether impaired
cell cycle entry and survival of p50    cRel    cells was due
to impaired expression of genes involved in the regulation
of these processes. A 6-h treatment of WT T cells with
 CD3 or  CD3  CD28 increased the expression of
mRNAs for IL-2, c-Myc, Bcl-2, and Bcl-xL (Fig. 2 B). On
the other hand, similar treatment of p50    cRel    cells
showed significantly impaired induction of IL-2 and Bcl-
xL whereas induction of c-Myc and Bcl-2 was also moder-
ately reduced. Thus, defects in cell cycle entry and/or sur-
vival of p50    cRel    T cells might be due to impaired
induction of expression of these key genes after TCR en-
gagement. Although our results do not demonstrate that
NF- B proteins directly regulate these genes, previous
studies have identified  B sites in control regions of these
genes (e.g., Bcl-xL; references 47 and 48), suggesting a pos-
sible direct role.
These results indicate potential defects in both cell cycle
entry and survival of p50    cRel    T cells. To specifically
determine whether p50    cRel    T cells exhibit a defect
in cell cycle control, both WT and p50    cRel    cells
were CFSE labeled and stimulated for 1–3 d with  CD3.
At the end of stimulation, dead cells were gated out during
FACS® and the level of CFSE was determined specifically
in the viable cell population. The level of CFSE was used
to determine the number of cell divisions that viable WT
and p50    cRel    T cells underwent after stimulation. As
shown in Fig. 3 A, either a 2- or 3-d  CD3 treatment led
to multiple cell divisions in WT T cells whereas the vast
majority of p50    cRel    did not undergo cell division.
As shown above, IL-2 expression was significantly reduced
in p50    cRel    cells. Therefore, we tested whether the
addition of exogenous IL-2 could allow p50    cRel    T
cell division. A 3-d treatment with  CD3 IL-2 moder-
ately increased the number of dividing p50    cRel    cells
(Fig. 3 B), but this number remained significantly
lower than WT cells treated with  CD3 alone or with
 CD3 IL-2. In contrast, CD28 costimulation was able to
significantly increase the number of p50    cRel    cells
that underwent cell division (consistent with the results
shown in Fig. 2 A). As shown in Fig. 3 B, bottom right, a
majority of WT cells stimulated with  CD3 CD28 IL-2
divided three to four times over a 3-d period. In contrast,
the number of p50    cRel    cells that underwent more
than two cell divisions when stimulated in the same man-
ner was significantly reduced. Furthermore, most p50   
cRel    cells failed to undergo even a single cell division.
Significantly, p50     cRel     T cells stimulated with
 CD3 CD28 IL-2 for 3 d expressed high levels of the
IL-2R  chain (CD25; Fig. 3 C), although less than in sim-
ilarly treated WT cells. These results indicate that impaired
cell cycle entry of p50    cRel    T cells is not due to lack
of responsiveness to stimulation. Instead, p50    cRel   
cells do undergo certain activation events, but fail to cycle.
Therefore, these results demonstrate a crucial role for NF-
Figure 2. Impaired cell cycle entry and sur-
vival after TCR stimulation of p50    cRel   
T cells. (A) WT and p50    cRel    CD4  T
cells were activated with plate-bound  CD3,
 CD3 IL-2,   CD3  CD28, or  CD3 
 CD28 IL-2 for 2 d before DNA content
staining and FACS® were performed. The per-
centages show the sub-G0 population, which
represents apoptotic cells and cells in different
phases of the cell cycle. Typical results of sev-
eral independent experiments are shown. (B)
RT-PCR was performed to determine ex-
pression of IL-2, c-Myc, Bcl2, and Bcl-XL in
WT and p50    cRel    CD4  T cells after
6 h of activation.T
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 B proteins in regulating TCR-induced cell division. In
addition, our results suggest that defects in cell division are
not due to impaired IL-2 or IL-2R expression.
Increased Cell Death in Activated p50    cRel    T Cells
Can Be Rescued by Bcl-2. The results shown above also
indicate that the activation of p50    cRel    T cells render
them more susceptible to cell death than WT T cells (Fig. 2
A). To test this possibility and the potential mechanisms in-
volved, WT and p50    cRel    cells were stimulated with
 CD3  CD28 for 3 d, after which viable cells were iso-
lated on a Ficoll gradient. These cells were then double la-
beled with  CD25 to detect activated T cells and the DNA
dye SYTOX to detect apoptotic cells. This method was
used to determine the percentage of activated T cells un-
dergoing apoptosis (i.e., CD25  SYTOX ) out of the total
number of CD25  cells (CD25  SYTOX  and CD25 
SYTOX ). As shown in Fig. 4 A, immediately after activa-
tion (day 0), only 5% WT and p50    cRel    Ficoll-iso-
lated cells were apoptotic. In the absence of stimulation,
activated T cells rapidly undergo cell death. After 1 d in
culture without stimulation,  25% activated CD25  WT
T cells underwent cell death. In contrast, 75% of CD25 
p50    cRel    cells underwent cell death over the same
period. Thus, activated p50    cRel    cells are signifi-
cantly more susceptible to cell death than WT cells. There-
fore, these results demonstrate that NF- B proteins play an
essential role in regulating not only cell division (Fig. 3),
but also survival of activated T cells.
As shown in Fig. 2 B, expression of Bcl-2 was moder-
ately reduced whereas expression of Bcl-xL was dramati-
cally impaired in p50    cRel    T cells after TCR engage-
ment. Importantly, it has been shown that Bcl-2 and Bcl-xL
inhibit cell death by biochemically similar mechanisms (49).
Therefore, we wanted to determine whether impaired sur-
vival of activated p50    cRel    cells was due to decreased
expression of these Bcl-2 family members after TCR en-
gagement. To this end, we first infected p50    cRel    T
cells with a GFP-expressing polycistronic retrovirus (MIG;
reference 16). All GFP  p50    cRel    cells were also
CD25  because oncoretroviruses can only infect proliferat-
ing cells (Fig. 4 B; reference 50). WT and p50    cRel    T
cells were then infected with MIG or MIG-Bcl-2 and incu-
bated for 2 d without stimulation, after which the percent-
age of viable infected cells (GFP  PI ) cells was determined.
Although, as expected, WT T cells underwent less death
than p50    cRel    T cells, their survival was enhanced by
Bcl-2 expression (Fig. 4 C). Of  24% p50    cRel    T
cells infected with MIG-GFP, only 8% survived after 2 d in
culture (Fig. 4 C). In contrast, survival of Bcl-2 retrovirus-
infected p50    cRel    T cells was dramatically enhanced
compared with MIG-infected T cells. Together with the
above findings, these results suggest that increased suscepti-
bility of p50    cRel    cells to apoptosis is due to impaired
TCR-induced expression of Bcl-2 family members.
IL-2-induced Survival Pathway Does Not Require p50 
cRel. T cell proliferation and survival is dependent
on TCR CD28– and cytokine- (e.g., IL-2) driven path-
ways. During early stages of activation, before significant
generation of antiapoptotic cytokines and/or expression of
cytokine receptors, TCR-driven pathways predominate.
Figure 3. Impaired cell divi-
sion of p50    cRel    CD4  T
cells after activation. (A and B)
WT and p50    cRel    CD4  T
cells were CFSE labeled and acti-
vated under different conditions
as shown for 1–3 d. FACS® was
performed on viable cells by gat-
ing on the forward and side scat-
ter characteristics. As shown in
the bottom right of B, peaks/
shoulders represent the number
of times cells underwent division.
The percentage indicates cell
population that has divided at
least once. (C) FACS® analysis of
CD25 (IL-2R ) expression on
WT and p50    cRel    CD4  T
cells after 3 d of activation by
plate-bound  CD3  CD28 and
IL-2.T
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As described above, increased susceptibility of p50   
cRel    cells to apoptosis is likely due to impaired TCR-
induced expression of Bcl-2 family members. In addition,
impaired IL-2 expression may also contribute to increased
susceptibility of p50    cRel    T cells to apoptosis (dis-
cussed later). Although the addition of IL-2 did not prevent
p50    cRel    or WT T cell death during initial stages of
TCR-induced activation (Fig. 2 A), this could be due to
lack of sufficient IL-2R  expression. Here we have investi-
gated a possible biochemical requirement for NF- B in the
IL-2–induced survival pathway in T cells activated with
 CD3  CD28 for 3 d. As shown above, expression of
IL-2R  is significantly enhanced in both WT and p50   
cRel    T cells activated with  CD3  CD28 for 3 d (Fig.
3 C and see below). These activated T cells were further
cultured in the presence or absence of IL-2 for 1 or 2 d. As
shown in Fig. 5, survival of both activated WT cells and
p50    cRel    was dramatically enhanced by IL-2. Thus,
although IL-2R   expression is a little lower in p50   
cRel    T cells (Fig. 3 C), it is sufficient for potent en-
hancement of survival by IL-2. However, this does not
preclude that other aspects of IL-2 function are also unaf-
fected in p50    cRel    T cells. Consistent with the above
results, we have found that Bcl-2 family members, previ-
ously shown to be induced by IL-2 (16, 51), were also in-
duced by IL-2 in p50    cRel    T cells (unpublished
data). Therefore, these results indicate an essential require-
ment for NF- B in the TCR-induced but not IL-2–induced
survival pathway.
Constitutive NF- B Activation Is Sufficient to Promote Acti-
vated T Cell Survival. Our results indicate that NF- B ac-
tivation by TCR engagement is necessary for T cell sur-
vival. Next, we determined whether NF- B is sufficient to
promote activated T cell survival in the absence of stimula-
tion. We did this by using a complementation approach in-
volving retroviral transduction of WT T cells with a con-
stitutively active mutant (EM, refer to Materials and
Methods) of the NF- B–activating I B kinase   (CA-
IKK ; reference 39). Nuclear NF- B activity was readily
detected in WT CD4  T cells immediately after activation.
However, after a 12-h incubation without  CD3,  CD28,
nor IL-2, NF- B complex 1 completely disappeared
Figure 4. High susceptibility of activated p50    cRel    T cells to cell
death can be rescued by Bcl-2. (A) WT and p50    cRel    CD4  T cells
were activated by plate-coated  CD3  CD28 for 3 d after which dead
cells were removed on a Ficoll gradient. These cells were either stained
with PE- CD25 and SYTOX immediately (day 0) or cultured in T cell
medium without  CD3 or IL-2 for 24 h before PE- CD25 and SYTOX
staining (day 1). Apoptosis rate represent the percentage of CD25 
SYTOX  cells (apoptotic) in the total CD25  population. (B) p50   
cRel    CD4  T cells were infected with MIG retrovirus during a 4-d
stimulation in the presence of  CD3   CD28. On day 4, viable cells
were stained by  CD25 before FACS® analysis. (C) MIG and Bcl2 retro-
viral-infected WT and p50    cRel    CD4  T cells were obtained as de-
scribed in B, and either stained with PI and analyzed by FACS® immedi-
ately (day 0) or cultured in T cell medium without  CD3 or IL-2 for 2 d
before PI staining and FACS® (day 2). The viable infected cells were
GFP  PI . The percentage was calculated based on the percentage of
GFP  PI  cells in the total cell population. The increase in the percentage
of Bcl-2–infected cells after 2 d in this experiment is likely due to the de-
crease in the number of uninfected cells because of cell death, rather than
an increase in the absolute number of Bcl-2–infected cells.
Figure 5. IL-2–induced survival pathway does not require p50 cRel.
 CD3  CD28–activated WT and p50    cRel    CD4  T cells were
cultured in T cell medium alone or in the presence of 20 ng/ml IL-2 for
1 or 2 d. Cell death was determined by DNA content staining and
sub-G0 quantification.T
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868 NF- B Function in Mature T Cells
whereas complex 2 was also reduced (Fig. 6 A). As shown
in Fig. 6 B, MIG/GFP-infected T cells also showed almost
complete loss of NF- B activity after 12 h (infection effi-
ciencies in this experiment and others described later varied
from 30 to 40%). In contrast, CA-IKK –expressing T cells
were able to maintain high NF- B levels after 12 h.
We then tested the effect of continued presence of NF-
 B on T cell survival. As shown above, cessation of TCR
engagement leads to the induction of activated T cell
death. After 3 d without stimulation, the number of MIG-
infected T cells was greatly reduced (Fig. 6, C and D). In
striking contrast, IKK -infected T cells showed no loss of
viability (Fig. 6, C and D). As expected, retrovirus-medi-
ated expression of Bcl-2 also substantially enhanced survival
compared with MIG-infected T cells (Fig. 6, C and D).
Significantly, only survival of IKK -infected but not unin-
fected T cells was enhanced (Fig. 6 C). These results indi-
cate that the survival-promoting effect of IKK  is likely
mediated by a cell-intrinsic mechanism rather than through
enhancement of cytokine production (e.g., IL-2), which
would also be expected to affect survival of uninfected cells
(also see below). These results suggest that the maintenance
of NF- B activity is sufficient for promoting T cell sur-
vival, likely by a cell-intrinsic mechanism.
Next, we determined whether enhanced survival of
IKK -expressing T cells was due to an increase in the ex-
pression of Bcl-2 family members. Both Bcl-2 and Bcl-xL
mRNAs were readily detected in T cells immediately after
activation (Fig. 6 E). However, a 12-h incubation of MIG-
infected cells led to a significant reduction in expression of
both Bcl-2 and Bcl-xL. In contrast, IKK  expression was
sufficient to maintain expression of both genes (Fig. 6 E).
Thus, NF- B activity is sufficient for maintaining expres-
sion of these key antiapoptotic genes. Interestingly, al-
though Bcl-2 and Bcl-xL mRNAs levels were greatly re-
duced by 12 h, significant reduction in Bcl-2 and Bcl-xL
protein levels were only seen after 2–3 d (unpublished
data). Thus, the loss of Bcl-2 and Bcl-xL protein levels
better correlate with the kinetics of T cell death (Fig. 6, C
and D). We also tested whether activated T cell death in-
duced after antigen deprivation could be inhibited by
IKK . To this end, OVA-specific OT-II T cells (36) were
infected with MIG or IKK  during a 3-d stimulation with
antigen. Significantly, cell death induced after antigen dep-
rivation was also inhibited by IKK  (Fig. 6 F). Because IL-2
is an NF- B target gene, we used OT-II T cells to deter-
mine whether IL-2 was required for IKK -induced en-
hancement of survival. As shown in Fig. 6 F, survival of
Figure 6. NF- B activation is sufficient
to promote T cell survival. (A)
 CD3  CD28 IL-2–activated WT
CD4  T cells were either used to make nu-
clear extract immediately or cultured in T
cell medium without stimulation for 12 h
before nuclear extract was made. EMSA
was performed with an H2 site probe. The
two complexes are described in the text. (B)
MIG and CA-IKK   retrovirus-infected
WT CD4  T cells were used immediately
(0 h) or cultured in T cell medium without
stimulation for 12 h. Nuclear extracts were
made and EMSA was performed with the
H2 site probe. (C and D) MIG, CA-IKK ,
and Bcl2 retrovirus-infected WT T cells
were cultured in T cell medium without
stimulation for 0, 1, 2, or 3 d, after which
cells were stained with PI and analyzed by
FACS®. FACS® data on days 0 and 3 are
shown in C. The percentage indicates the
proportion of GFP  PI  cells in total cell
population. The percentage survival of in-
fected T cells from days 0 to 3 are shown in
D. (E) MIG, CA-IKK , and Bcl2 retrovi-
ral-infected WT T cells were cultured in T
cell medium without  CD3 or IL-2 for
12 h. RNA was extracted before and after
culturing. Bcl2, Bcl-XL, and   actin expres-
sion was examined by Northern blotting. 1,
endogenously expressed Bcl2; 2, ectopically
expressed Bcl2. (F) MIG, CA-IKK  retro-
virus-infected OT-II IL-2 /   and OT-
II IL-2    T cells were cultured in T cell
medium without stimulation for 0–3 d. Sur-
vival rate of the infected cells was deter-
mined by PI staining and FACS® analysis as
in C and D.T
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OT-II IL-2    could also be enhanced by IKK . To-
gether, these results lead us to two key conclusions: (a)
NF- B activation is sufficient to promote T cell survival
by an IL-2–independent and likely cell-intrinsic mecha-
nism, and (b) down-regulation of NF- B after termination
of TCR engagement may play a crucial role in inducing
activated T cell death.
Lack of Involvement of p50 cRel in Akt-induced T Cell Sur-
vival. Similar to other cell types, Akt has been shown to
play an important role in regulating the survival of T cells.
NF- B is thought to be one of the key mediators of Akt-
induced inhibition of cell death (18, 21). Furthermore,
Akt-induced NF- B activation has been shown to require
IKK  (20). Using p50    cRel    T cells, we also investi-
gated a possible role of NF- B in Akt-mediated control of
T cell survival. Infection of WT T cells with constitutively
active (myr mutant) Akt (15) or CA-IKK –encoding ret-
rovirus substantially inhibited cell death (Fig. 7). On the
other hand, IKK  expression in p50    cRel    T cells did
not inhibit cell death (Fig. 7), further demonstrating the ab-
sence of functional NF- B activity in these cells. In striking
contrast, Akt expression significantly inhibited cell death of
p50    cRel    cells (Fig. 7). Therefore, these surprising re-
sults suggest a lack of requirement for NF- B in regulating
the Akt-induced survival pathway in T cells (see Discus-
sion). Thus, NF- B and Akt-induced pathways may inde-
pendently regulate survival of T cells.
Impaired Antigen Responsiveness In Vivo and Decreased Pro-
portion of Effector/Memory and Regulatory T Cells in p50   
cRel    Mice. Very little is known about the function of
NF- B proteins in regulating T cell responses in vivo. Al-
though the results described above indicate an important
role for NF- B in regulating T cell function in vitro, in
vivo regulatory mechanisms can often be different. To test
the in vivo role of NF- B in T cell responses, mice were
challenged with the superantigen SEB, a widely used re-
agent to study antigen-induced responses in vivo (52, 53).
SEB specifically binds to TCRs that contain the V 8 ele-
ment and drive their expansion (52). SEB-mediated T cell
responses require TCR expression on T cells and MHC II
expression on APC, notably DCs. Significantly, p50   
cRel    mice have normal DC development and MHC II
expression on spleen DCs (unpublished data and reference
27). Both WT and p50    cRel    mice were injected in-
travenously with SEB and the percentage of CD4  V 8  T
cells in total CD4  T cells was determined at days 0 (unin-
jected), 3, and 6. In addition, CD4  V 6  T cell numbers
were also determined at the same periods as negative con-
trols. SEB does not bind to TCRs containing this V  ele-
ment. As shown in Fig. 8 A, in WT mice, the CD4  V 8 
T cell population increased from  24 to  32% 3 d after
SEB injection and then dropped to  22% on day 6. The
kinetics of these changes in cell numbers is consistent with
previous reports (53). The initial increase in V 8  T cells
results from a proliferative response (day 3) whereas the de-
crease is due to cell death (day 6; reference 53). The CD4 
V 6  T cell population remained unchanged during the
same period, demonstrating the specificity of the SEB re-
sponse for V 8  T cells. In contrast to their WT counter-
parts, CD4  V 8  T cell populations in p50    cRel   
mice showed no increase after SEB injection. Instead, over
a 6-d period, V 8  T cells dropped from  23 to  16%
(Fig. 8 A). The CD4  V 6  T cells in these mice were not
altered during the same period. These results support our in
vitro findings and suggest that impaired SEB responsiveness
of p50    cRel    T cells in vivo is due to defects in prolif-
eration and survival.
It is generally believed that memory T cells are derived
from a small subset of effector T cells activated during a
primary immune response (54, 55). The proportion of
memory T cells in unchallenged mice increases with age,
likely through interactions with environmental antigens.
Because p50    cRel    T cells showed impaired prolifera-
tion and survival after activation in vivo, we investigated
whether memory T cell development was affected in these
mice. Spleen cells from 3- and 8-wk-old WT and p50   
cRel    mice were stained with CD4, CD44, and CD62L
antibodies and FACS® analysis was performed on gated
Figure 7. Lack of involvement of p50 cRel in Akt-
induced T cell survival. MIG, myr-AKT, and CA-
IKK   retrovirus-infected WT and p50     cRel   
CD4  T cells were cultured in T cell medium without
 CD3 or IL-2 for 1 or 2 d. Survival rate of the infected
cells was determined by PI staining and FACS® analysis
as in Fig. 6, C and D.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
870 NF- B Function in Mature T Cells
CD4  cells. As shown in Fig. 8 B, naive T cells were iden-
tified as the CD44low CD62L  population and memory T
cells as the CD44high CD62L  population (55). Strikingly,
3-wk-old WT mice had approximately threefold more ef-
fector/memory T cells than p50    cRel    mice (21.8
vs. 7%) whereas in 8-wk-old mice the difference was
 2.5-fold (24 vs. 10.5%). Thus, the proportion of mem-
ory T cells is significantly reduced in p50    cRel   
mice. We also tested regulatory T cell (CD4  CD25 )
populations in WT and p50    cRel    mice. In 2-mo-
old p50    cRel    mice, CD4  CD25  T cells were
reduced fivefold compared with WT mice (Fig. 8 C).
Significantly, the differentiation of naive T cells into ef-
fector, memory, and regulatory T cells requires initial an-
tigen-induced activation. Therefore, the decreased num-
bers of all three populations in p50    cRel    mice are
consistent with our results showing impaired in vitro and
in vivo proliferation and survival of p50    cRel    T
cells. Together, these results show for the first time an
important role for NF- B in regulating mature T cell
function in vivo.
Discussion
Multiple signaling pathways are induced during mature
T cell activation that together regulate proliferation, sur-
vival, and cytokine production. However, the precise role
of specific signaling molecules and transcription factors in
regulating these pathways is not well understood. To this
end, we have studied the role of the NF- B transcription
factor in mature T cells by using doubly deficient p50   
cRel    T cells, which exhibit virtually no TCR-inducible
 B site binding activity. Our results demonstrate an essen-
tial role for NF- B in regulating cell cycle entry and sur-
vival of activated T cells in vitro and in vivo. These results
indicate that of the many transcription factors considered
important in T cells, NF- B might be among the most
crucial. The findings reported here help us understand
many key aspects of regulatory mechanisms involved in T
cell function.
Regulation of T Cell Survival by NF- B. A primary goal
of this study was to elucidate NF- B–dependent mecha-
nisms involved in regulating T cell survival. We have
found, using both in vitro and in vivo approaches, that
NF- B activation after TCR engagement plays a crucial
role in regulating T cell survival. Significantly, our results
indicate that NF- B activation is not only necessary but
also sufficient for T cell survival. We have also found that
NF- B plays an essential role in TCR-induced regulation
of Bcl-2 and Bcl-xL gene expression. Significantly, the
high susceptibility of activated p50    cRel    T cells to
apoptosis was inhibited by retroviral expression of Bcl-2,
suggesting that NF- B prevents cell death by regulating
Bcl-2 family member expression. These findings establish a
critically important function of NF- B in TCR-induced
regulation of survival. Our results also demonstrate that
the combined absence of p50 and cRel subunits is re-
quired for significant impairment of mature T cell func-
tion. Although cRel    T cells were thought to have
greatly impaired proliferation (35), we have previously
found relatively intact responsiveness in these and p50   
T cells (28). Thus, our findings with p50    cRel    T
Figure 8. Impaired antigen-induced responses and effector/memory
and regulatory T cell generation in WT and p50    cRel    mice. (A)
WT and p50    cRel    mice were either uninjected (day 0) or injected
with SEB. V 8  and V 6  T cell populations were determined 3 and 6 d
after injection. Two mice of each genotype were used per condition. (B)
Naive and memory T cell populations were determined using 3- and
8-wk-old WT and p50    cRel    mice. Splenocytes from these mice
were stained with CD4, CD44, and CD62L antibodies. FACS® analysis
was performed on gated CD4  T cells. Naive T cells were CD44low
CD62L  and memory T cells were CD44high CD62L . (C) Splenocytes
from 2-mo-old WT and p50    cRel    mice were stained with CD4
and CD25. FACS® analysis was performed on gated CD4  T cells.T
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cells indicate redundant functions for these two proteins in
mature T cells.
p50    cRel    T cells show impaired IL-2 expression
after activation. Thus, the antiapoptotic function of NF- B
may involve both TCR induction of expression of Bcl-2
family members and IL-2. We believe both these NF- B–
dependent mechanisms are important, but at different
stages. During the initial TCR-dependent phase of activa-
tion (1–2 d), i.e., before there is significant generation of
antiapoptotic cytokines and/or expression of cytokine re-
ceptors, NF- B directly induces expression of Bcl-2 family
members and enhances activated T cell survival (Fig. 2).
The ability of NF- B to enhance survival in a cytokine-
(e.g., IL-2) independent manner is further evidenced by
IKK  transduction studies with WT and IL-2    T cells
(Fig. 6). At this early stage, T cell survival might be regu-
lated by cooperative interactions between NF- B and
other TCR CD28–induced pathways. During later stages
of T cell activation (3–4 d), cytokine-driven responses
likely predominate. At this stage, NF- B may also enhance
survival through generation of antiapoptotic cytokines,
such as IL-2. Interestingly, we have shown a lack of in-
volvement of NF- B in the IL-2–induced survival path-
way. Thus, although NF- B is important for IL-2 expres-
sion, it is not a mediator of IL-2–induced survival, which
also depends on Bcl-2 family members. Thus, T cell sur-
vival can be controlled independently or through coopera-
tive regulation of Bcl-2 family expression by TCR CD28
and cytokine-induced pathways. It was recently shown that
T cell activation and generation of memory/effector T cells
can still occur in  c-deficient mice (56), which are nonre-
sponsive to many cytokines important for T cell function
including IL-2, IL-4, IL-7, and IL-15. It is interesting to
speculate whether immune responses in these mice are me-
diated largely by TCR-induced NF- B activation.
A key question is why TCR engagement induces an an-
tiapoptotic pathway in the first place. One reason might be
to block simultaneously induced apoptotic pathways for T
cell expansion to occur. It has recently been shown that
TCR signals lead to activation of Bim, a proapoptotic
member of the Bcl-2 family (7, 57). TCR signals also lead
to generation of reactive oxygen species in activated T
cells, which contribute to induction of apoptosis (58). This
would be consistent with the function of Bcl-2 proteins,
which are known to inhibit apoptosis induced by reactive
oxygen species (59, 60). However, an additional function
of antiapoptotic pathways may also allow efficient removal
of activated T cells once TCR stimulation ends. Because
continued antiapoptotic pathway activation will depend on
TCR signaling, this would allow rapid elimination of T
cells when TCR engagement ends. Such cell death may
occur as a result of down-regulation of one or multiple an-
tiapoptotic signaling pathways. We have shown here that
nuclear NF- B levels rapidly decline in WT T cells after
cessation of TCR stimulation, an event that was concomi-
tant with induction of cell death. However, T cells com-
plemented with a retrovirus-encoding CA-IKK   main-
tained nuclear NF- B levels and survived in the absence of
stimulation. Thus, NF- B activation is not only sufficient
to promote T cell survival but down-regulation of NF- B
can also provide a mechanism for induction of cell death.
Although IKK  expression apparently enhances survival in
a cell-intrinsic manner by inducing Bcl-2 family member
expression, it is likely that down-regulation of NF- B after
termination of TCR engagement leads to apoptosis both
through decreased expression of Bcl-2 proteins and cyto-
kines such as IL-2.
The PKB/Akt kinase is a key mediator of T cell survival
pathways and has previously been shown to function
through NF- B (19–21, 61). However, our results show
that Akt but not IKK  is fully capable of enhancing p50   
cRel    T cell survival. In addition, we have found that the
PI3K inhibitor LY294002, which inhibits Akt activation,
does not inhibit  CD3  CD28–induced NF- B activa-
tion in WT T cells (unpublished data). Furthermore, IL-2
induces Akt but not NF- B activation in T cells (unpub-
lished data). Together, these different findings strongly sug-
gest that NF- B may not be a mediator of the Akt-induced
survival pathway. Therefore, these results indicate the ex-
istence of two parallel and potentially independent survival
pathways in T cells. They may also help explain how IL-2,
which activates Akt, enhances the survival of p50    cRel   
T cells. In addition, Akt is also thought to be a key media-
tor of CD28-induced responses. However, CD28-induced
responses are generally evident only in the presence of
TCR engagement. Because TCR-induced NF- B itself is
so crucial for survival, it is difficult to determine the specific
role of NF- B in the CD28 survival pathway using p50   
cRel    T cells (the role NF- B in CD28-induced prolif-
eration is discussed below). The potentially NF- B–
independent nature of Akt prosurvival function suggests
the existence of alternate Akt-induced mechanisms for
regulating Bcl-2 family member expression. Although
the identity of such transcription factors is presently un-
known, they may include members of signal transducer
and activator of transcription, Ets, or AP-1 families. In-
terestingly, we have also found that activated p50   
cRel    T cells, similar to T cells deficient in p50   ,
RelA   , or cRel    (28), are no more susceptible to
Fas-induced killing than WT T cells (unpublished data).
These results indicate that a distinct survival pathway
might be required for regulating Fas killing and further
underscore a specific function for NF- B in regulating
TCR-induced survival.
Immunological adjuvants were shown to induce expres-
sion of the I B family member Bcl-3 in T cells, resulting in
enhanced T cell survival (62). These results, together with
our findings, suggest that Bcl-3 likely enhances transcrip-
tional functions of NF- B in T cells. One interesting possi-
bility might be that Bcl-3 promotes T cell survival by
maintaining NF- B nuclear activity in the absence of TCR
engagement. Gene targeting studies of PKC  and Bcl-10
have revealed an essential role for these proteins in NF- B
activation and in regulating T cell proliferative responses
(32, 33). Based on our results with p50    cRel    T cells,
it is possible that impaired proliferation of T cells deficientT
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in PKC  or Bcl-10 might be due to defects in both cell di-
vision and cell survival.
Control of T Cell Proliferation and Effector/Memory and Reg-
ulatory T Cell Generation by NF- B. We have found that
in addition to regulating survival, NF- B proteins also reg-
ulate CD4  T cell proliferation. TCR-induced cell cycle
entry of p50    cRel    T cells is both significantly re-
duced and delayed compared with WT T cells. Previous
studies have implicated NF- B as a key component of the
CD28 costimulatory pathway (63, 64). However, our re-
sults indicate that CD28 could significantly increase prolif-
eration of p50    cRel    T cells, suggesting that NF- B
control of proliferation might be more specific for the
TCR pathway. One possibility is that CD28-induced en-
hancement of p50     cRel     T cell proliferation is
through Akt-induced pathways. In addition to NF- B,
CD28 also induces activation of the AP-1 family of tran-
scription factors. Thus, AP-1 factors may play a more cru-
cial role in the CD28 pathway than NF- B and CD28-
induced AP-1 activity may synergize with TCR-induced
NF- B and NFAT pathways in regulating T cell prolifera-
tion, survival, and other functions. Interestingly, PKC    
T cells are deficient in both NF- B and AP-1 activation
(33). Comparative analysis of T cell function in PKC    
and p50    cRel    mice may therefore help us better un-
derstand the specific role played by AP-1 in regulating T
cell proliferation.
IL-2 expression was significantly reduced in p50   
cRel    cells, but the addition of exogenous IL-2 failed to
rescue proliferation defects. p50    cRel    cells, however,
express IL-2R and are protected from cell death by IL-2.
Thus, impaired proliferative responses cannot simply be
due to reduced IL-2 or IL-2R expression, but instead may
result from impaired TCR induction of genes involved in
cell cycle control. The identity of such NF- B–regulated
genes has yet to be determined. One of the important find-
ings reported here is the decreased number of effector/
memory and regulatory T cells in p50    cRel    mice.
Because differentiation of naive T cells into effector, mem-
ory, and regulatory T cells requires antigen-induced activa-
tion, these results provide further evidence for the crucial
role of NF- B in regulating activation-induced prolifera-
tion and survival of T cells. However, our results also indi-
cate that a certain proportion of effector/memory T cells
are generated in p50    cRel    mice, which appear to in-
crease with age. One possibility is that decreased effector/
memory T cell in p50    cRel    mice are a consequence
of impaired proliferation and/or survival during a primary
response. However, the small number of effector/memory
T cells that do form in p50    cRel    mice may undergo
expansion by cytokine-driven homeostatic mechanisms,
which might not require NF- B.
NF- B Function in T Cell Development. Consistent with
our findings, previous studies of I B-Tg mice have also
shown impaired proliferative responses and IL-2 expres-
sion, but unlike p50    cRel    mice, I B-Tg mice also
showed impaired thymocyte development and reduction in
numbers of peripheral T cells (29–31). The effect was espe-
cially pronounced for the CD8 lineage (29–31). As recently
shown, impaired thymocyte development likely reflects a
requirement for NF- B in regulating survival of develop-
ing thymocytes (65). Unlike mature T cells (Fig. 1 E),
p50    cRel    thymocytes still exhibit low levels of RelA
(unpublished data). Thus, RelA may play an important role
in the development of thymocytes in the absence of p50
and cRel. Notably, a proapoptotic role for NF- B in thy-
mocytes has also been proposed (30, 66). Thus, although
the findings presented here demonstrate a crucial role for
NF- B in mature T cells, the precise role played by NF-
 B in thymocytes remains to be determined.
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